Player FM ऐप के साथ ऑफ़लाइन जाएं!
पॉडकास्ट सुनने लायक
प्रायोजित
![From Creative Passion To Profit podcast artwork](https://cdn.player.fm/images/54246369/series/tBc6icen2GmDMA2n/32.jpg 32w, https://cdn.player.fm/images/54246369/series/tBc6icen2GmDMA2n/64.jpg 64w, https://cdn.player.fm/images/54246369/series/tBc6icen2GmDMA2n/128.jpg 128w, https://cdn.player.fm/images/54246369/series/tBc6icen2GmDMA2n/256.jpg 256w, https://cdn.player.fm/images/54246369/series/tBc6icen2GmDMA2n/512.jpg 512w)
![From Creative Passion To Profit podcast artwork](/static/images/64pixel.png)
1 How creatives can budget for regular income! 7:18
#24 A week in the name of medicines safety – part 1
Manage episode 424661241 series 2749727
To mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Tune in to find out:
- Why under-reporting plagues all pharmacovigilance systems
- What regulators can do to encourage people to report side effects
- Why we need reports from both patients and healthcare professionals
Want to know more?
Here are the studies cited in the episode:
- A BMJ study in 2022 measured the burden and associated cost of adverse drug reactions, polypharmacy and multimorbidity at a hospital in the UK.
- In 1976, Inman proposed a theoretical model, known as the ‘seven deadly sins’, to explain why healthcare professionals fail to report adverse drug reactions. This recent systematic review in Drug Safety expands on that.
- The SCOPE Joint Action project aimed to enhance pharmacovigilance in the EU and delivered practical guidance for regulators.
- The first UK study to compare Yellow Card reports from patients and healthcare professionals was published in 2012.
To join the #MedSafetyWeek campaign next week, follow the hashtag online and check out the campaign website for free social media materials.
Finally, don’t forget to tune in on 13 November for part 2 of this podcast, where we’ll hear from #MedSafetyWeek advocates in Iraq, Luxembourg, and Namibia about their experience with the campaign. Read a preview of the conversation on Uppsala Reports.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
अध्यायों
1. #24 A week in the name of medicines safety – part 1 (00:00:00)
2. Intro (00:00:15)
3. Welcome, Mitul! (00:01:49)
4. Why we need communications campaigns (00:01:58)
5. Barriers to reporting (00:06:07)
6. Different reporters, different perspectives (00:09:45)
7. Other interventions to prompt reporting (00:14:23)
8. Global versus local (00:19:08)
9. Future of #MedSafetyWeek (00:22:55)
10. Outro (00:25:19)
52 एपिसोडस
Manage episode 424661241 series 2749727
To mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Tune in to find out:
- Why under-reporting plagues all pharmacovigilance systems
- What regulators can do to encourage people to report side effects
- Why we need reports from both patients and healthcare professionals
Want to know more?
Here are the studies cited in the episode:
- A BMJ study in 2022 measured the burden and associated cost of adverse drug reactions, polypharmacy and multimorbidity at a hospital in the UK.
- In 1976, Inman proposed a theoretical model, known as the ‘seven deadly sins’, to explain why healthcare professionals fail to report adverse drug reactions. This recent systematic review in Drug Safety expands on that.
- The SCOPE Joint Action project aimed to enhance pharmacovigilance in the EU and delivered practical guidance for regulators.
- The first UK study to compare Yellow Card reports from patients and healthcare professionals was published in 2012.
To join the #MedSafetyWeek campaign next week, follow the hashtag online and check out the campaign website for free social media materials.
Finally, don’t forget to tune in on 13 November for part 2 of this podcast, where we’ll hear from #MedSafetyWeek advocates in Iraq, Luxembourg, and Namibia about their experience with the campaign. Read a preview of the conversation on Uppsala Reports.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
अध्यायों
1. #24 A week in the name of medicines safety – part 1 (00:00:00)
2. Intro (00:00:15)
3. Welcome, Mitul! (00:01:49)
4. Why we need communications campaigns (00:01:58)
5. Barriers to reporting (00:06:07)
6. Different reporters, different perspectives (00:09:45)
7. Other interventions to prompt reporting (00:14:23)
8. Global versus local (00:19:08)
9. Future of #MedSafetyWeek (00:22:55)
10. Outro (00:25:19)
52 एपिसोडस
सभी एपिसोड
×![Artwork](/static/images/128pixel.png)
1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
![Artwork](/static/images/128pixel.png)
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
![Artwork](/static/images/128pixel.png)
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
![Artwork](/static/images/128pixel.png)
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
![Artwork](/static/images/128pixel.png)
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
![Artwork](/static/images/128pixel.png)
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
![Artwork](/static/images/128pixel.png)
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
![Artwork](/static/images/128pixel.png)
1 #28 Catching black swans – François Montastruc 27:21
![Artwork](/static/images/128pixel.png)
1 #27 When drugs damage the liver – Rita Baião 28:30
![Artwork](/static/images/128pixel.png)
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
![Artwork](/static/images/128pixel.png)
1 #25 A week in the name of medicines safety – part 2 33:13
![Artwork](/static/images/128pixel.png)
1 #24 A week in the name of medicines safety – part 1 27:09
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – The colour of signals 33:59
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।